Lantheus pioneers next-generation solutions—from precision diagnostics to radiopharmaceuticals—that help improve outcomes and lives.

Delivering life-changing science for more than 65 years, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics, and artificial intelligence solutions, enabling clinicians to Find, Fight, and Follow disease.

At the American Urological Association (AUA), Lantheus promoted its exciting product, PYLARIFY®, a radioactive diagnostic agent used in PET scan imaging for men with prostate cancer.

The tagline, “Let’s be Clear,” signals that PYLARIFY® uses a radioactive tracer called fluorine-18 which helps create a clearer and more detailed PET/CT scan image for HCPs. A clearer image also provides improved insights, which can lead to more informed treatment choices.

Because PYLARIFY® makes PET scans transparent optically, “optical transparency” is the focal point of the exhibit design.

In the crossover world of trade show exhibits, our designer discovered a new display technology at the Consumer Electronics Show: a transparent LED screen called Holoscape.

At 8″ deep, the LED screen could stand on its own. The graphics were mounted to the front of the screen on ¾” Plexiglas™. The screen offered transparency yet allowed attendees to view the graphics.

Partnering with agency Jacques Madison, Access created a show-stopping display of images. As visitors walked through the exhibit, they encountered the therapeutic benefits of PYLARIFY® and entered a “clear world.”